BioRez Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 24

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $250M

BioRez General Information

Description

Developer of bio-inductive implants designed to harness the body's regenerative capacity to rebuild functional tissue and improve musculoskeletal outcomes. The company's bioresorbable scaffold technology stabilizes a surgical repair while the body regenerates its own musculoskeletal tissue to accelerate physical rehabilitation, thereby enabling patients to heal while providing surgeons with a convenient tool to improve and augment soft tissue repairs.

Contact Information

Website
www.biorez.com
Formerly Known As
Soft Tissue Regeneration
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 470 James Street
  • Suite 14
  • New Haven, CT 06513
  • United States
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Acquirer
Conmed
Vertical(s)
Life Sciences
Corporate Office
  • 470 James Street
  • Suite 14
  • New Haven, CT 06513
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioRez Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 09-Aug-2022 $250M Completed Generating Revenue
8. Secondary Transaction - Private 01-May-2022 Completed Generating Revenue
7. Seed Round 24-Jun-2021 Completed Generating Revenue
6. Later Stage VC 09-Sep-2020 Completed Generating Revenue
5. Later Stage VC (Series C1) 05-Mar-2018 Completed Generating Revenue
4. Later Stage VC (Series C) 05-Dec-2016 Completed Generating Revenue
3. Later Stage VC (Series B) 07-Nov-2014 Completed Generating Revenue
2. Early Stage VC (Series A1) 20-Apr-2010 $2.55M $7.55M Completed Generating Revenue
1. Early Stage VC (Series A) 02-Sep-2008 $5M $5M Completed Startup
To view BioRez’s complete valuation and funding history, request access »

BioRez Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed-3
Seed-2
Seed-1 1,789,174 $0.001000 8% $0.97 $0.97 1x $0.97 19.83%
To view BioRez’s complete cap table history, request access »

BioRez Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of bio-inductive implants designed to harness the body's regenerative capacity to rebuild functional tissue an
Therapeutic Devices
New Haven, CT
24 As of 2022

Memphis, TN
 

Sandy Springs, GA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioRez Competitors (7)

One of BioRez’s 7 competitors is NUsurface, a Venture Capital-Backed company based in Memphis, TN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NUsurface Venture Capital-Backed Memphis, TN
Artelon Formerly VC-backed Sandy Springs, GA
Miach Orthopaedics Venture Capital-Backed Westborough, MA
Embody (Therapeutic Devices) Formerly VC-backed Norfolk, VA
Orthopaedic Implant Company Formerly Angel backed Reno, NV
You’re viewing 5 of 7 competitors. Get the full list »

BioRez Patents

  • 78

    Total Documents Applications and Grants

  • Total Patents Families

  • 57

    Granted

  • 10

    Pending

  • Expiring in next 12 mo

BioRez Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021322190-A1 Composite scaffold for the repair, reconstruction, and regeneration of soft tissues Pending 03-Aug-2020
CA-3187896-A1 Composite scaffold for the repair, reconstruction, and regeneration of soft tissues Pending 03-Aug-2020
EP-4188469-A1 Composite scaffold for the repair, reconstruction, and regeneration of soft tissues Pending 03-Aug-2020
EP-4188469-A4 Composite scaffold for the repair, reconstruction, and regeneration of soft tissues Pending 03-Aug-2020
JP-2025013362-A Composite scaffold for repair, reconstruction and regeneration of soft tissues Pending 07-Feb-2019 A61F2/08
To view BioRez’s complete patent history, request access »

BioRez Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioRez Former Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Angel (individual) Minority
Bantam Group Other Minority
Brainchild (New York) Venture Capital Minority
Connecticut Innovations Venture Capital Minority
You’re viewing 5 of 17 investors. Get the full list »

Ready to get started?

Request a free trial

BioRez FAQs

  • When was BioRez founded?

    BioRez was founded in 2008.

  • Where is BioRez headquartered?

    BioRez is headquartered in New Haven, CT.

  • What is the size of BioRez?

    BioRez has 24 total employees.

  • What industry is BioRez in?

    BioRez’s primary industry is Therapeutic Devices.

  • Is BioRez a private or public company?

    BioRez is a Private company.

  • What is the current valuation of BioRez?

    The current valuation of BioRez is .

  • What is BioRez’s current revenue?

    The current revenue for BioRez is .

  • How much funding has BioRez raised over time?

    BioRez has raised $25.5M.

  • Who are BioRez’s investors?

    , , Bantam Group, Brainchild (New York), and Connecticut Innovations are 5 of 17 investors who have invested in BioRez.

  • Who are BioRez’s competitors?

    NUsurface, Artelon, Miach Orthopaedics, Embody (Therapeutic Devices), and Orthopaedic Implant Company are some of the 7 competitors of BioRez.

  • When was BioRez acquired?

    BioRez was acquired on 09-Aug-2022.

  • Who acquired BioRez?

    BioRez was acquired by Conmed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »